Our Research Areas
Awarded a Department of Defense Congressionally Directed Medical Research Program Exploration- Hypothesis Award in the area of bone marrow failure and received an award from the Cancer Prevention Research Institute of Texas.
As one of the top programs for cell-based therapies, our research focuses on improving transplantation outcomes by reducing or avoiding infection or relapses and investigating viral-specific cells.
The largest and most comprehensive bone tumor research program in the United States.
Physicians on the pediatric neuro-oncology research program work closely together to improve the cure rates for children with brain tumors by using the latest treatments available.
As one of the best pediatric cancer centers in the nation, experts in the care of childhood cancer are on the forefront of cutting-edge research and clinical trials.
The cancer genetics and genomics research laboratories occupy over 5,500 square feet of state-of-the-art laboratory space. The recently renovated areas are well equipped for research in genetics, genomics, and cellular and molecular biology.
Translational research takes laboratory information and “translates” it into the clinical setting. The program’s current research focuses on identifying survivors at risk for medical problems, such as heart or hormonal disturbances. A major focus of the program is also directed at early diagnosis and intervention for survivors with psychosocial and neuropsychological concerns.
Rapidly translating novel cell and gene therapy protocols from the laboratory to the clinic.
Nationally recognized as a major center for the development of novel chemotherapy approaches to pediatric cancer treatment.
Studying the causes of childhood cancer and hematological diseases to determine what can be done to prevent these conditions.
The Faris D. Virani Ewing Sarcoma Center has a strong emphasis on research. Our team has several targeted research goals, including developing a greater understanding of the:
We conduct state-of-the-art clinical and scientific research aimed at increasing our understanding of bleeding and clotting disorders and developing new, more effective therapies for children who suffer from them.
As one of the largest Histiocytosis Programs in the world, our internationally-recognized research discoveries have led to a better understanding of histiocytic diseases.
Actively researching the causes and treatments of these disorders as well as collaborating with leading centers around the country.